Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

IOSP vs MATV: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

IOSP Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 5–5 Matrix Metrics)

IOSP Overall Winner 6-Pillar Tally: IOSP 3 – 2 MATV (1 Tie) Matrix Metrics: IOSP 5 – 5 MATV

As of Nov 16, 2026, Innospec Inc. (IOSP) is the stronger overall head-to-head candidate over Mativ Holdings, Inc. (MATV) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, R&D & Supply-Chain Moat). IOSP carries a Unified Composite Score of 58.6/100 (HOLD) at $79.38 (13.5x Forward P/E, 8.5% operating margin), whereas MATV carries 52.8/100 (HOLD) at $11.67 (10.2x Forward P/E, 4.1% operating margin).

  • Technical & Structure Timing Caution: IOSP is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.1); meanwhile MATV is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About IOSP vs MATV
IOSP NASDAQ Head-to-Head Winner
Innospec Inc.
Chemicals & Allied Products
$79.38
-1.26% 1D
Market Cap $1.9B
TTM Revenue $1.87B
Forward P/E 13.5x
Beta / 30D Vol 0.27β · 68% Vol
Unified Composite Score
58.6 / 100 HOLD
Tech 60.0 Fund 55.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -1.5%), weak momentum, RSI 28
RSI-14: 28.1 · SMA20: $90.44 · SMA50: $93.54
MATV NYSE
Mativ Holdings, Inc.
Paper Mills
$11.67
-1.04% 1D
Market Cap $662.9M
TTM Revenue $1.97B
Forward P/E 10.2x
Beta / 30D Vol 0.77β · 52% Vol
Unified Composite Score
52.8 / 100 HOLD
Tech 49.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -1.7%) with fading momentum, RSI 48
RSI-14: 47.8 · SMA20: $11.78 · SMA50: $11.86

6-Pillar Scorecard Institutional Category Breakdown (IOSP 3 – 2 MATV)

Columns: Metric · IOSP · MATV
1. Valuation Multiples MATV
Forward P/E 13.5x 10.2x
Trailing P/E 13.8x 7.2x
PEG Ratio 0.66x 1.84x
EV / Revenue 1.0x 0.3x
2. Growth & Scale IOSP
Revenue Growth (YoY) +7.2% -2.8%
Earnings Growth (YoY) +148.3% N/A
TTM Revenue (USD) $1.87B $1.97B
Market Cap $1.9B $662.9M
3. Profitability & Quality IOSP
Gross Margin 27.7% 19.4%
Operating Margin 8.5% 4.1%
Net Profit Margin 7.5% 4.6%
Return on Equity (ROE) 10.4% 21.2%
4. Balance Sheet & Cash Flow MATV
Cash Generation (TTM) $198M EBITDA $215M EBITDA
Cash Flow Margin 10.6% EBITDA Mgn 10.9% EBITDA Mgn
Net Cash / Leverage $55.74 Book/Sh · 10.4% ROE $8.46 Book/Sh · 21.2% ROE
Dividend Yield 2.29% 3.23%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 31.0% (47th %ile) 56.0% (7th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Distribution
6. R&D & Supply-Chain Moat IOSP
OpEx & R&D Intensity 19.2% of Rev ($360M) 15.3% of Rev ($302M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Specialty Chemicals Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: IOSP (5) vs MATV (5)
Institutional Metric IOSP MATV Criterion Row Edge
Market Capitalization
Scale
$1.9B $662.9M Larger Scale IOSP
Trailing P/E Ratio
Valuation
13.8x 7.2x Lower Multiple MATV
Forward P/E Ratio
Valuation
13.5x 10.2x Lower Multiple MATV
Revenue Growth (YoY)
Growth
+7.2% -2.8% Higher Growth IOSP
Operating Margin (TTM)
Profitability
8.5% 4.1% Higher Margin IOSP
Net Profit Margin
Profitability
7.5% 4.6% Higher Margin IOSP
Return on Equity (ROE)
Capital Efficiency
10.4% 21.2% Higher ROE MATV
52-Week Range Position
Momentum
38% ($66–$102) 55% ($7–$15) Stronger Trend MATV
Beta / 30D Volatility
Risk Regime
0.27β · 68% Vol 0.77β · 52% Vol Lower Realized Risk MATV
Unified Institutional Score
Composite Signal
58.6 / 100 (HOLD) 52.8 / 100 (HOLD) Higher Composite IOSP
Trailing 12M Revenue (USD)
Operating Scale
$1.87B $1.97B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
27.7% 19.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.66x PEG · 1.0x EV/Rev 1.84x PEG · 0.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$198M EBITDA ($55.74 Book/Sh · 10.4% ROE) $215M EBITDA ($8.46 Book/Sh · 21.2% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MATV +22.09 pp
IOSP: -18.01% · MATV: +4.08%
3M Horizon MATV +11.82 pp
IOSP: -15.16% · MATV: -3.34%
6M Horizon MATV +39.99 pp
IOSP: +0.41% · MATV: +40.4%
1Y Horizon IOSP +17.71 pp
IOSP: +6.16% · MATV: -11.55%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IOSP vs MATV. Trailing 12-month operating profitability (IOSP 8.5% vs MATV 4.1%) and valuation multiples (IOSP 13.5x vs MATV 10.2x Forward P/E) are benchmarked directly in Pillar 4 below.

IOSP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.87B
Gross Margin27.7%
Op. Margin8.5%
ROE / Fwd P/E10.4% · 13.5x
MATV ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.97B
Gross Margin19.4%
Op. Margin4.1%
ROE / Fwd P/E21.2% · 10.2x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
IOSP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 31.0%
IV Percentile 47th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IOSP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MATV UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 56.0%
IV Percentile 7th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MATV Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
IOSP Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $1.9B market capitalization and 8.5% operating margin.
OpEx & R&D Reinvestment 19.2% of Rev ($360M)
90D Engineering Disclosures 0 Published
MATV Moat Profile Scale & Operating Efficiency Moat
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $662.9M market capitalization and 4.1% operating margin.
OpEx & R&D Reinvestment 15.3% of Rev ($302M)
90D Engineering Disclosures 0 Published

Investor FAQ IOSP vs MATV Key Questions & Quantitative Answers

As of Nov 16, 2026, Innospec Inc. (IOSP) is the stronger overall head-to-head candidate over Mativ Holdings, Inc. (MATV) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, R&D & Supply-Chain Moat). IOSP carries a Unified Composite Score of 58.6/100 (HOLD) at $79.38 (13.5x Forward P/E, 8.5% operating margin), whereas MATV carries 52.8/100 (HOLD) at $11.67 (10.2x Forward P/E, 4.1% operating margin). Technical & Structure Timing Caution: IOSP is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.1); meanwhile MATV is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

IOSP leads the Growth & Scale pillar: IOSP posts +7.2% YoY revenue growth and +148.3% YoY earnings growth on $1.87B TTM revenue (27.7% gross margin, 8.5% operating margin), compared with MATV at -2.8% YoY revenue growth and N/A YoY earnings growth on $1.97B TTM revenue (19.4% gross margin, 4.1% operating margin). On trailing 12-month operating scale, IOSP generates $1.87B in USD-normalized revenue versus $1.97B for MATV. In operating R&D and SG&A reinvestment, IOSP deploys 19.2% of Rev ($360M) (0 90-day corporate R&D disclosures) versus 15.3% of Rev ($302M) (0 disclosures) for MATV.

MATV screens cheaper on headline valuation multiples. IOSP trades at 13.5x Forward P/E, 13.8x Trailing P/E, 0.66x PEG, and 1.0x EV/Revenue (10.6% EBITDA margin), whereas MATV trades at 10.2x Forward P/E, 7.2x Trailing P/E, 1.84x PEG, and 0.3x EV/Revenue (10.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IOSP (10.4% ROE) versus MATV (21.2% ROE) capital efficiency.

In options market volatility and institutional positioning, IOSP carries 31.0% implied volatility (47th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.27β · 68% Vol realized risk). By comparison, MATV carries 56.0% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.77β · 52% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.